CO86 Clinical Outcomes of Diabetic Macular Edema Patients Treated With Faricimab and Aflibercept: A Subcohort Analysis of 20/50 or Worse Visual Acuity Across Faricimab Phase 3 Clinical Trials

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.165
https://www.valueinhealthjournal.com/article/S1098-3015(22)02369-5/fulltext
Title : CO86 Clinical Outcomes of Diabetic Macular Edema Patients Treated With Faricimab and Aflibercept: A Subcohort Analysis of 20/50 or Worse Visual Acuity Across Faricimab Phase 3 Clinical Trials
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02369-5&doi=10.1016/j.jval.2022.09.165
First page :
Section Title :
Open access? : No
Section Order : 11233
Categories :
Tags :
Regions :
ViH Article Tags :